These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8064009)

  • 1. Generalized vitiligo preceded by a generalized figurate erythematosquamous eruption.
    Arata J; Abe-Matsuura Y
    J Dermatol; 1994 Jun; 21(6):438-41. PubMed ID: 8064009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneously active lesions of vitiligo and erythema dyschromicum perstans.
    Henderson CD; Tschen JA; Schaefer DG
    Arch Dermatol; 1988 Aug; 124(8):1258-60. PubMed ID: 3401033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coexistence of erythema dyschromicum perstans and vitiligo: a case report and review of the literature.
    Tamer F
    Acta Dermatovenerol Alp Pannonica Adriat; 2016 Dec; 25(4):77-78. PubMed ID: 28006880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colocalization of lichen planus and vitiligo associated with selective IgA deficiency.
    Gül U; Soylu S; Demiriz M
    Skinmed; 2007; 6(4):202-3. PubMed ID: 17618176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A figurate papulosquamous variant of inflammatory vitiligo.
    Lee D; Lazova R; Bolognia JL
    Dermatology; 2000; 200(3):270-4. PubMed ID: 10828641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphic light eruption limited to areas of vitiligo.
    Downs AM; Lear JT; Dunnill MG
    Clin Exp Dermatol; 1999 Sep; 24(5):379-81. PubMed ID: 10564326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal changes in active vitiligo.
    Hann SK; Park YK; Lee KG; Choi EH; Im S
    J Dermatol; 1992 Apr; 19(4):217-22. PubMed ID: 1607483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and histopathologic characteristics of trichrome vitiligo.
    Hann SK; Kim YS; Yoo JH; Chun YS
    J Am Acad Dermatol; 2000 Apr; 42(4):589-96. PubMed ID: 10727303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photolichenoid plaques with associated vitiliginous pigmentary changes.
    Tran K; Hartman R; Tzu J; Meehan S; Sanders SE; Pomeranz MK; Sanchez M
    Dermatol Online J; 2011 Oct; 17(10):13. PubMed ID: 22031639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory changes in vitiligo: stage I and II depigmentation.
    Sharquie KE; Mehenna SH; Naji AA; Al-Azzawi H
    Am J Dermatopathol; 2004 Apr; 26(2):108-12. PubMed ID: 15024191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical Analysis of GDNF and Its Cognate Receptor GFRα-1 Protein Expression in Vitiliginous Skin Lesions.
    Adly MA; Assaf HA; Abdel-Rady SF; Ahmed NS; Hussein MR
    J Cutan Med Surg; 2016; 20(2):130-4. PubMed ID: 26337382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eruptive facial lentiginosis-like repigmentation in a patient with longstanding generalized vitiligo without a detectable trigger.
    Kaiser D; Hosta V; Loubser J; Pavlović MD
    Acta Dermatovenerol Alp Pannonica Adriat; 2022 Mar; 31(Suppl):S25-S26. PubMed ID: 35339139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of PUVA therapy on melanocytes and keratinocytes in non-segmental vitiligo: histopathological, immuno-histochemical and ultrastructural study.
    Anbar TS; El-Sawy AE; Attia SK; Barakat MT; Moftah NH; El-Ammawy TS; Abdel-Rahman AT; El-Tonsy MH
    Photodermatol Photoimmunol Photomed; 2012 Feb; 28(1):17-25. PubMed ID: 22211999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pentachrome vitiligo.
    Fargnoli MC; Bolognia JL
    J Am Acad Dermatol; 1995 Nov; 33(5 Pt 2):853-6. PubMed ID: 7593796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psoralen plus ultraviolet A irradiation-induced lentigines arising in vitiligo: involvement of vitiliginous and normal appearing skin.
    Abdel Naser MB; Wollina U; El Okby M; El Shiemy S
    Clin Exp Dermatol; 2004 Jul; 29(4):380-2. PubMed ID: 15245535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical markers of vitiligo activity.
    Benzekri L; Gauthier Y
    J Am Acad Dermatol; 2017 May; 76(5):856-862. PubMed ID: 28245942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermatoscopy of blue vitiligo.
    Chandrashekar L
    Clin Exp Dermatol; 2009 Jul; 34(5):e125-6. PubMed ID: 19438538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased anthralin irritation response in vitiliginous skin.
    Westerhof W; Buehre Y; Pavel S; Bos JD; Das PK; Krieg SR; Siddiqui AH
    Arch Dermatol Res; 1989; 281(1):52-6. PubMed ID: 2730143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitiligo with an inflammatory erythema in Vogt-Koyanagi-Harada disease: demonstration of filamentous masses and amyloid deposits.
    Kumakiri M; Kimura T; Miura Y; Tagawa Y
    J Cutan Pathol; 1982 Aug; 9(4):258-66. PubMed ID: 7119218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical expression of aberrant Notch-1 signaling in vitiligo: an implication for pathogenesis.
    Seleit I; Bakry OA; Abdou AG; Dawoud NM
    Ann Diagn Pathol; 2014 Jun; 18(3):117-24. PubMed ID: 24560443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.